Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study.

Heinemann, Klaas; Imthurn, Bruno; Marions, Lena; Gerlinger, Christoph; Becker, Kerstin; Moehner, Sabine; Faustmann, Thomas

Heinemann, Klaas; Imthurn, Bruno; Marions, Lena; Gerlinger, Christoph; Becker, Kerstin; Moehner, Sabine; Faustmann, Thomas.

Afiliação

Heinemann K; ZEG Berlin, 10115, Berlin, Germany. k.heinemann@zeg-berlin.de.
Imthurn B; Department of Reproductive Endocrinology, University Hospital Zurich, 8091, Zurich, Switzerland.
Marions L; Department of Clinical Science and Education, Karolinska Institutet, 118 83, Stockholm, Sweden.
Gerlinger C; Statistics and Data Insights, Bayer AG, 13553, Berlin, Germany.
Becker K; Gynecology, Obstetrics and Reproductive Medicine, University Medical School of Saarland, 66421, Homburg, Saar, Germany.
Moehner S; ZEG Berlin, 10115, Berlin, Germany.
Faustmann T; ZEG Berlin, 10115, Berlin, Germany.

Adv Ther ; 37(5): 2528-2537, 2020 05.

Article em En | MEDLINE | ID: mdl-32301063

Assuntos

Endometriose/tratamento farmacológico; Antagonistas de Hormônios/uso terapêutico; Nandrolona/análogos & derivados; Adulto; Endometriose/complicações; Europa (Continente); Feminino; Alemanha; Antagonistas de Hormônios/efeitos adversos; Humanos; Nandrolona/efeitos adversos; Nandrolona/uso terapêutico; Dor Pélvica/tratamento farmacológico; Dor Pélvica/etiologia; Estudos Prospectivos; Projetos de Pesquisa; Saúde da Mulher

Palavras-chave

Dienogest; Endometriosis; Hormonal treatment; Observational; Prospective; Real-world evidence; Women's health

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Antagonistas de Hormônios / Nandrolona Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google